Total Payments
$6,888
2024 Payments
$391.22
Companies
47
Transactions
452
Medicare Patients
2,796
Medicare Billing
$312,168
Payment Breakdown by Category
Food & Beverage$6,886 (100.0%)
Education$1.88 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,886 | 451 | 100.0% |
| Education | $1.88 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,720 | 126 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,183 | 83 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $812.41 | 53 | $0 (2022) |
| Biogen, Inc. | $412.16 | 27 | $0 (2022) |
| Allergan, Inc. | $410.79 | 36 | $0 (2022) |
| Celgene Corporation | $225.23 | 15 | $0 (2023) |
| UCB, Inc. | $180.04 | 10 | $0 (2023) |
| PFIZER INC. | $170.95 | 11 | $0 (2024) |
| Amgen Inc. | $147.01 | 8 | $0 (2023) |
| Horizon Therapeutics plc | $116.40 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $391.22 | 21 | ABBVIE INC. ($162.24) |
| 2023 | $500.43 | 30 | ABBVIE INC. ($174.95) |
| 2022 | $1,008 | 72 | ABBVIE INC. ($534.43) |
| 2021 | $1,769 | 119 | AbbVie Inc. ($848.58) |
| 2020 | $806.07 | 60 | Novartis Pharmaceuticals Corporation ($257.38) |
| 2019 | $1,277 | 75 | Teva Pharmaceuticals USA, Inc. ($244.67) |
| 2018 | $659.00 | 42 | Novartis Pharmaceuticals Corporation ($263.62) |
| 2017 | $477.42 | 33 | Novartis Pharmaceuticals Corporation ($217.20) |
All Payment Transactions
452 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Neurology | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/08/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $38.85 | General |
| Category: NEUROLOGY | ||||||
| 07/11/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 07/09/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: PAIN | ||||||
| 06/08/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Vercise_NMD | ||||||
| 04/22/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Genetic Disease | ||||||
| 04/16/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: Neurology | ||||||
| 04/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/22/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Neurology | ||||||
| 12/21/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Musculoskeletal | ||||||
| 12/20/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $15.97 | General |
| 12/14/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 265 | 363 | $73,467 | $25,694 |
| 2022 | 14 | 823 | 1,227 | $171,437 | $86,477 |
| 2021 | 15 | 901 | 1,380 | $195,916 | $104,143 |
| 2020 | 16 | 807 | 1,427 | $182,742 | $95,854 |
Total Patients
2,796
Total Services
4,397
Medicare Billing
$312,168
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 101 | $21,425 | $7,511 | 35.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 87 | $11,560 | $4,911 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $17,044 | $4,817 | 28.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $12,036 | $3,441 | 28.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 22 | $4,800 | $1,876 | 39.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 25 | 27 | $2,025 | $1,131 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $2,897 | $1,063 | 36.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 17 | 28 | $1,680 | $943.43 | 56.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 155 | 158 | $44,240 | $22,461 | 50.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 136 | 383 | $38,300 | $19,354 | 50.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 164 | $24,940 | $12,474 | 50.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $12,420 | $6,051 | 48.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 68 | $10,200 | $5,175 | 50.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 109 | 121 | $9,075 | $5,143 | 56.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 71 | 129 | $7,740 | $4,297 | 55.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 15 | 16 | $6,560 | $4,215 | 64.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $4,060 | $2,152 | 53.0% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 32 | 32 | $5,600 | $1,789 | 32.0% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 21 | 21 | $4,200 | $1,637 | 39.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,090 | $964.22 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,272 | $464.03 | 36.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 15 | 15 | $450.00 | $215.32 | 47.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 29 | $290.00 | $85.80 | 29.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 163 | 172 | $48,160 | $25,778 | 53.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 148 | 453 | $45,300 | $24,607 | 54.3% |
About Dr. William Hewitt, MD
Dr. William Hewitt, MD is a Neurology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184668501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Hewitt, MD has received a total of $6,888 in payments from pharmaceutical and medical device companies, with $391.22 received in 2024. These payments were reported across 452 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($6,886).
As a Medicare-enrolled provider, Hewitt has provided services to 2,796 Medicare beneficiaries, totaling 4,397 services with total Medicare billing of $312,168. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology, Neurology
- Location Mobile, AL
- Active Since 06/15/2006
- Last Updated 03/30/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1184668501
Products in Payments
- UBRELVY (Drug) $1,139
- GILENYA (Drug) $449.68
- AIMOVIG (Biological) $351.88
- QULIPTA (Drug) $351.86
- BOTOX (Biological) $340.84
- AJOVY (Biological) $310.84
- AJOVY (Drug) $307.84
- KESIMPTA (Drug) $297.70
- TYSABRI (Biological) $262.41
- ZEPOSIA (Drug) $259.17
- Aimovig (Biological) $147.01
- COPAXONE (Drug) $141.69
- DUOPA (Drug) $118.71
- UPLIZNA (Drug) $116.40
- Briviact (Drug) $98.08
- INGREZZA (Drug) $88.16
- TROKENDI XR (Drug) $86.25
- GOCOVRI (Drug) $83.45
- Radicava (Drug) $77.68
- Xeomin (Biological) $74.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Mobile
Dr. Daniel Dees, M.d, M.D
Neurology — Payments: $803,515
Neurology $803,515
Dr. Hayden Long, Md, MD
Neurology — Payments: $295,347
Neurology $295,347
Dr. Charles Markle, M.d, M.D
Neurology — Payments: $265,994
Neurology $265,994
Dean Naritoku, M.d, M.D
Neurology — Payments: $250,962
Neurology $250,962
Bassam Bassam, Md, MD
Neurology — Payments: $139,121
Neurology $139,121
Dr. Juan Ochoa, Md, MD
Neurology — Payments: $88,415
Neurology $88,415